Efficacy and Safety of Oral Chelators in Treatment of Patients With Wilson Disease Karl Heinz Weiss, Florentine Thurik, Daniel Nils Gotthardt, Mark Schäfer,

Slides:

Advertisements

Similar presentations

Efficacy and Safety of Oral Chelators in Treatment of Patients With Wilson Disease Karl Heinz Weiss, Florentine Thurik, Daniel Nils Gotthardt, Mark Schäfer,

Advertisements

The Role of Psychosocial Care in Adapting to Health Care Reform

Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F

Severity of Organ Failure Is an Independent Predictor of Intracranial Hypertension in Acute Liver Failure Reinhard Kitzberger, Georg Christian Funk,

Saurabh Dawra, Vishal Sharma, Usha Dutta

Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.

Noncardiac Chest Pain Clinical Gastroenterology and Hepatology

Nitsan Maharshak, Scott E. Plevy

Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure Stephen J.D. O'Keefe, Palle B. Jeppesen,

Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.

Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure Stephen J.D. O'Keefe, Palle B. Jeppesen,

A Shocking Cystory Clinical Gastroenterology and Hepatology

Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment- Naïve Patients With Chronic Hepatitis C Albert Friedrich Stättermayer,

Right Upper Quadrant Pain and a Normal Abdominal Ultrasound

Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis Anita Sainsbury, David S. Sanders, Alexander C.

Inflammation But Not Biliary Obstruction Is Associated With Carbohydrate Antigen 19-9 Levels in Patients With Primary Sclerosing Cholangitis Andreas.

Diffuse Gastric Wall Thickening: Appearances Can Be Deceptive

A 5-Year Prospective Observational Study of the Outcomes of International Treatment Guidelines for Crohn's Disease Garret Cullen, Denise Keegan, Hugh.

Volume 138, Issue 2, Pages e1 (February 2010)

Fasiha Kanwal, MD, MSHS, Hashem B. El-Serag, MD, MPH

Issue Highlights Clinical Gastroenterology and Hepatology

Racial and Ethnic Differences in Presentation, Etiology, and Outcomes of Acute Liver Failure in the United States Kimberly A. Forde, K. Rajender Reddy,

Late-Onset Wilson’s Disease

Clinical Features, Treatment, and Survival of Patients With Colorectal Cancer With or Without Inflammatory Bowel Disease Raja Affendi Raja Ali, Cara.

Proximal Esophageal Varices: A Rare Yet Treatable Cause of Hemorrhage

Early Virologic Responses and Hematologic Safety of Direct-Acting Antiviral Therapies in Veterans With Chronic Hepatitis C Pamela S. Belperio, Elizabeth.

Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H

Activity-Based Costing and Management in a Hospital-Based GI Unit

Volume 140, Issue 4, Pages e1 (April 2011)

Alan J. Wigg, Rosemary McCormick, Rachel Wundke, Richard J. Woodman

Amie L. Harvey, Tommy Yen, Anand Kunda

AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review Jean-Frederic Colombel,

Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea Reginald V. Fant,

Patrick Hoversten, Fouad Otaki, David A. Katzka

Rohan M. Modi, Christina A. Arnold, Peter P. Stanich

Obstructive Jaundice Caused by Intraductal Hepatocellular Carcinoma

Gastroenterology in a New Era of Accountability: Part 2

New Models of Gastroenterology Practice

Efficacy and Safety of a Magnesium Sulfate–Rich Natural Mineral Water for Patients With Functional Constipation Christophe Dupont, Alain Campagne, Florence.

Effect of Human Immunodeficiency Virus and Antiretrovirals on Outcomes of Hepatitis C: A Systematic Review From an Epidemiologic Perspective Jennifer.

George N. Ioannou, Meaghan F. Splan, Noel S. Weiss, George B

Evaluation of the Patient-Reported Outcomes Measurement Information System in a Large Cohort of Patients With Inflammatory Bowel Diseases Michael D.

David H. Bruining, William J. Sandborn

Peter Bytzer Clinical Gastroenterology and Hepatology

Patients With Celiac Disease Are Not Followed Up Adequately

Long-term Outcome of Perianal Fistulizing Crohn's Disease Treated With Infliximab Guillaume Bouguen, Laurent Siproudhis, Emmanuel Gizard, Timothée Wallenhorst,

Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome Lilian Dindo, PhD Clinical Gastroenterology.

Issue Highlights Clinical Gastroenterology and Hepatology

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial Manish Kumar Lunia, Barjesh Chander Sharma, Praveen.

Hepatic Cyst? Clinical Gastroenterology and Hepatology

Christos Konstantakis, Maria Karamesini, Christos Triantos

Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication Lauren A. Beste, George.

Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States Zobair M. Younossi, Maria Stepanova

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Minimal-Change Esophagitis on Narrow-Band Imaging

Failure to Renew Prescriptions for Gastroprotective Agents to Patients on Continuous Nonsteroidal Anti-inflammatory Drugs Increases Rate of Upper Gastrointestinal.

Coagulation in Liver Disease: A Guide for the Clinician

Issue Highlights Clinical Gastroenterology and Hepatology

Issue Highlights Clinical Gastroenterology and Hepatology

Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism? John S. Leeds, David S. Sanders

Volume 135, Issue 2, Pages (August 2008)

Coloduodenal Fistula in Crohn’s Disease

Rintaro Hashimoto, Akimichi Chonan

Adverse Outcomes: Why Bad Things Happen to Good People

Medical Therapy for Refractory Pediatric Crohn’s Disease

Rintaro Hashimoto, Akimichi Chonan

The Role of Psychosocial Care in Adapting to Health Care Reform

Subcapsular Hepatic Fluid Collection Caused by Cardiac Dysfunction

Jordan E. Axelrad, Sharyle A. Fowler, Sonia Friedman, Ashwin N

Presentation transcript:

Efficacy and Safety of Oral Chelators in Treatment of Patients With Wilson Disease Karl Heinz Weiss, Florentine Thurik, Daniel Nils Gotthardt, Mark Schäfer, Ulrike Teufel, Franziska Wiegand, Uta Merle, Daniela Ferenci– Foerster, Andreas Maieron, Rudolf Stauber, Heinz Zoller, Hartmut H. Schmidt, Ulrike Reuner, Harald Hefter, Jean Marc Trocello, Roderick H.J. Houwen, Peter Ferenci, Wolfgang Stremmel Clinical Gastroenterology and Hepatology Volume 11, Issue 8, Pages 1028-1035.e2 (August 2013) DOI: 10.1016/j.cgh.2013.03.012 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Number of treatments in the study cohort. Hepatic and neurologic outcomes were scored for each treatment at defined time points (6, 12, 24, 36, and 48 mo) as follows: improved to normal, improved but not normal, unchanged, worsened, or asymptomatic over duration. Combination therapies (25 treatments with DPA and zinc; 21 treatments with trientine and zinc) were not included in the numbers provided in this flow chart and were not included in the statistical analysis. Clinical Gastroenterology and Hepatology 2013 11, 1028-1035.e2DOI: (10.1016/j.cgh.2013.03.012) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Discontinuation of treatments for (A) any cause or because of (B) adverse events, analyzed by Kaplan–Meier estimation. Clinical Gastroenterology and Hepatology 2013 11, 1028-1035.e2DOI: (10.1016/j.cgh.2013.03.012) Copyright © 2013 AGA Institute Terms and Conditions